Literatura académica sobre el tema "Vaccination – Immunologie"

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Vaccination – Immunologie".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Vaccination – Immunologie"

1

Confer, A. W., R. J. Panciera, M. J. Gentry, and R. W. Fulton. "Immunologie response to Pasteurella haemolytica and resistance against experimental bovine pneumonic pasteurellosis, induced by bacterins in oil adjuvants." American Journal of Veterinary Research 48, no. 2 (1987): 163–68. https://doi.org/10.2460/ajvr.1987.48.02.163.

Texto completo
Resumen
SUMMARY Immunogenicity of and protection afforded by Pasteurella haemolytica bacterins were studied in calves. Bacterins contained an aluminum hydroxide in gel (alh) adjuvant or one of the following oil-in-water adjuvants: Freund's complete adjuvant (fca), Freund's incomplete adjuvant (fia), and trehalose dimycolate (tdm). On days 0 and 7, calves were vaccinated with phosphate-buffered saline solution (pbss), a bacterin, or live P haemolytica. Transthoracic intrapulmonic challenge exposure was done on day 21. In 3 experiments, there were no significant (P > 0.05) differences between lung le
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Bazin, Hervé. "L’histoire des vaccinations. 2e partie : des vaccins pastoriens aux vaccins modernes." Bulletin de la Société Française d'Histoire de la Médecine et des Sciences Vétérinaires 13, no. 1 (2013): 45–63. https://doi.org/10.3406/bhsv.2013.1146.

Texto completo
Resumen
Cette présentation concerne la mise en route des vaccins à virulence atténuée par Pasteur et son équipe, donnant l’espoir d’obtenir un vaccin pour chaque maladie infectieuse. De nombreuses techniques ont été mises en oeuvre : vaccins chimiques, sérothérapie, séro-vaccination, vaccins tués (microbes) ou inactivés (virus), auto-vaccins, anatoxines, irradiation de parasites… pour les vaccins de première génération. La naissance de la biologie moléculaire et du génie génétique en microbiologie et en immunologie a conduit à une explosion de vaccins OGM dont les premiers exemples sont le vaccin hépa
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Olsen, S. C., and C. Johnson. "Immune Responses and Safety after Dart or Booster Vaccination of Bison with Brucella abortus Strain RB51." Clinical and Vaccine Immunology 19, no. 5 (2012): 642–48. http://dx.doi.org/10.1128/cvi.00033-12.

Texto completo
Resumen
ABSTRACTOne alternative for management of brucellosis in Yellowstone National Park bison (Bison bison) is vaccination of calves and yearlings. AlthoughBrucella abortusstrain RB51 vaccination protects bison against experimental challenge, the effect of booster vaccinations was unknown. This study characterized immunologic responses after dart or booster vaccination of bison withBrucella abortusstrain RB51. In two studies, 8- to 10-month-old female bison were inoculated with saline (n= 14), hand vaccinated with 1.1 × 1010to 2.0 × 1010CFU of RB51 (n= 21), or dart vaccinated with 1.8 × 1010CFU of
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Ridolfi, Irene, Luca Lo Sardo, Stefania Nicola, et al. "MAURIVAX: A Vaccination Campaign Project in a Hospital Environment for Patients Affected by Autoimmune Diseases and Adult Primary Immunodeficiencies." Vaccines 11, no. 10 (2023): 1579. http://dx.doi.org/10.3390/vaccines11101579.

Texto completo
Resumen
Background: Patients with autoimmune diseases (ADs) and primary immunodeficiencies (PIDs) are characterized by an increased risk of noninvasive and widespread infections as they are considered frail patients. In addition, many flares of the underlying disease are reported after routine vaccinations. To date, the vaccination rate in these two populations is suboptimal. According to the latest guidelines, targeted interventions are needed, such as strengthening the network of vaccination activities. Our project aimed to propose a pilot network for carrying out the recommended vaccinations in fra
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Rosenblat, Todd L., Mark G. Frattini, Suzanne M. Chanel, et al. "Phase II Trial of WT1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR)." Blood 120, no. 21 (2012): 3624. http://dx.doi.org/10.1182/blood.v120.21.3624.3624.

Texto completo
Resumen
Abstract Abstract 3624 WT1 is a transcription factor which has been implicated in leukemogenesis and has been used as a marker of minimal residual disease (MRD). We previously demonstrated the feasibility of vaccinating AML patients in CR with a multivalent WT1 peptide vaccine and inducing immune responses. In an effort to further explore the safety and efficacy of this approach, we are conducting a Phase II study in which the vaccine is administered to AML patients in first CR and who completed all planned postremission chemotherapy. Eligible patients had WT1 transcript detectable by RT-PCR.
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Gates, Dana M., Steven A. Cohen, Kelly Orr, and Aisling R. Caffrey. "Pharmacist-Administered Influenza Vaccination in Children and Corresponding Regulations." Vaccines 10, no. 9 (2022): 1410. http://dx.doi.org/10.3390/vaccines10091410.

Texto completo
Resumen
In our retrospective cohort study, we evaluated trends in pharmacist-administered pediatric influenza vaccination rates in the United States and corresponding state-level pharmacist pediatric vaccination authorization models, including minimum age requirements, vaccination protocols, and/or prescription requirements. An administrative health claims database was used to capture influenza vaccinations in children less than 18 years old with 1 year of continuous enrollment and joinpoint regression was used to assess trends. Of the 3,937,376 pediatric influenza vaccinations identified over the stu
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Buckwalter, Matthew, and Pramod Srivastava. "Form of antigen dictates immunity: Irradiated cell vs. whole cell lysate vaccination (48.16)." Journal of Immunology 178, no. 1_Supplement (2007): S77. http://dx.doi.org/10.4049/jimmunol.178.supp.48.16.

Texto completo
Resumen
Abstract The context in which antigen is perceived by the immune system dictates the quality of the ensuing immune response, which can range from tolerance to lasting immunity. In the current report we investigated the effects of vaccinating mice with antigen in two separate contexts, namely: Irradiated cells, or whole cell lysates. Using the MethA tumor model we observed that although a single vaccination with irradiated MethA cells leads to immunity in BALB/c mice, vaccination with the same cell equivalents of whole cell lysate does not. These results were surprising in light of the substant
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Huppke, L., C. Gebhardt, L. Grümme, et al. "AB1326 DIFFERENCES IN ADVERSE EVENTS EXPERIENCED BY INDIVIDUALS WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY INDIVIDUALS AFTER SARS-CoV-2 VACCINATION." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1892.1–1892. http://dx.doi.org/10.1136/annrheumdis-2023-eular.497.

Texto completo
Resumen
BackgroundSince individuals with inflammatory rheumatic diseases (IRDs) were excluded from the SARS-CoV-2 vaccination trials (1), uncertainty on the tolerability of the vaccines in this population was high. This caused a lower willingness to be vaccinated compared to the general population. Gaining more information on vaccine reaction in this population is critical.ObjectivesThe aim of the study was to improve knowledge of the tolerability of SARS-CoV-2 vaccination in patients with IRD and to identify potential specific risks of this population by comparison with a healthy cohort.MethodsIRD pa
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Wu, Yufei, Huanjie Li, Yangyang Wang, et al. "Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines." Vaccines 10, no. 5 (2022): 647. http://dx.doi.org/10.3390/vaccines10050647.

Texto completo
Resumen
As the third year of the global COVID-19 pandemic, vaccination remains the most effective tool against infections and symptomatic illness. Comprehension regarding immunity to SARS-CoV-2 is limited, and the durability of immune responses after vaccination is currently not clear. In this study, we randomly collected 395 questionnaires to analyze the current state of COVID-19 vaccination. At the same time, the serum of 16 individuals who had received two doses of the COVID-19 vaccine were collected at different times before and after the booster vaccination. We analyzed the dynamic changes of SAR
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Robinson, Stacie J., Michelle M. Barbieri, Samantha Murphy, et al. "Model recommendations meet management reality: implementation and evaluation of a network-informed vaccination effort for endangered Hawaiian monk seals." Proceedings of the Royal Society B: Biological Sciences 285, no. 1870 (2018): 20171899. http://dx.doi.org/10.1098/rspb.2017.1899.

Texto completo
Resumen
Where disease threatens endangered wildlife populations, substantial resources are required for management actions such as vaccination. While network models provide a promising tool for identifying key spreaders and prioritizing efforts to maximize efficiency, population-scale vaccination remains rare, providing few opportunities to evaluate performance of model-informed strategies under realistic scenarios. Because the endangered Hawaiian monk seal could be heavily impacted by disease threats such as morbillivirus, we implemented a prophylactic vaccination programme. We used contact networks
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Vaccination – Immunologie"

1

Baey, Camille. "Etude de l’efficacité et des mécanismes de la présentation croisée d’antigènes cellulaires tumoraux intacts par les cellules dendritiques." Thesis, Paris 5, 2013. http://www.theses.fr/2013PA05T054/document.

Texto completo
Resumen
Les cellules dendritiques (DC) sont spécialisées dans la capture, l’apprêtement et la présentation des antigènes. Elles ont développé une voie spécifique de présentation, la présentation croisée, leur permettant d’internaliser des antigènes exogènes, de les digérer et de les associer aux molécules du CMH de classe I afin de les présenter aux lymphocytes T CD8+. La présentation croisée est essentielle à la présentation d’antigènes qui ne sont pas synthétisés directement dans les DC (antigènes du soi, de tumeurs, de microorganismes n’infectant pas les DC) et donc à l’établissement de réponses T
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Beignon, Anne-Sophie. "Exploitation du système immunitaire de la peau pour l'administration non-invasive de vaccins." Université Louis Pasteur (Strasbourg) (1971-2008), 2002. http://www.theses.fr/2002STR13068.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Leite, Pereira Adrien. "Découverte de marqueurs immunologiques permettant d’évaluer l’innocuité des nouveaux vaccins." Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLS177.

Texto completo
Resumen
La vaccination est souvent mal perçue par la population générale. Pour rassurer cette dernière, il serait intéressant de créer une plateforme vaccinale pouvant prédire, in vitro, les risques associés à la prise d’un vaccin. L’objectif de cette thèse est de mettre au point les prémices de cette plateforme. Le principe est simple: obtenir la signature inflammatoire d’un vaccin candidat pour évaluer son innocuité. Pour cela, cette signature sera comparée à celles obtenues par des vaccins actuellement sur le marché ou induites par des pathogènes.Durant cette thèse, nous avons sélectionné une liste
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Mahé, Brice. "Etude de la vaccination par la voie transcutanée : modèles expérimentaux et études cliniques." Paris 6, 2007. http://www.theses.fr/2007PA066470.

Texto completo
Resumen
La récente implication de DCs cutanées dans le mécanisme de présentation croisée et l’induction de réponses T CD8+ suggère que la vaccination transcutanée soit une voie adéquate favorisant les réponses immunes cellulaires. D’une part, le modèle murin nous a permis d’établir in vivo que suite à l’application transcutanée de nanoparticules (40/200 Nm) un afflux de ces nanoparticules atteignait le ganglion drainant la zone traitée. D’autre part, l’utilisation de vecteurs viraux modifiés, comme le MVA (Modified Virus Ankara), nous a permis d’établir que des immunogènes de taille plus importante (≈
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Dupuy-Papin, Catherine. "Vaccination anti-papillomavirus : réponse systémique et vaginale contre la protéine majeure de capside." Tours, 1998. http://www.theses.fr/1998TOUR3813.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Gross, David Alexandre. "Identification et optimisation d'antigènes tumoraux en vue d'une vaccination antitumorale." Paris 6, 2001. http://www.theses.fr/2001PA066432.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Çobanoglu, Özmen. "Contribution de la sénescence cellulaire à la vaccination anti-tumorale chez l’individu âgé." Electronic Thesis or Diss., Université de Lille (2022-....), 2023. http://www.theses.fr/2023ULILS083.

Texto completo
Resumen
Le déclin du système immunitaire naturellement lié à l'âge - appelé immunosénescence - contribue à la moindre efficacité des vaccins chez les personnes âgées. La sénescence cellulaire est caractérisée par une inflammation chronique de bas grade. Les cellules sénescentes s'accumulent avec l'âge et sont résistantes à la mort cellulaire, notamment du fait de l'augmentation de l'expression des membres de la famille Bcl-2. Les cellules sénescentes produisent de nombreux facteurs inflammatoires et des immunomodulateurs, ce qui contribue à l'expression de leurs fonctions délétères. Ces cellules cause
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Deutscher, Mathieu Meyer Gilles. "Infection expérimentale par le virus respiratoire syncytial bovin étude des interactions entre la vaccination et l'évolution du virus /." [S.l.] : [s.n.], 2007. http://oatao.univ-toulouse.fr/1798/1/celdran_1798.pdf.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Haddad, Nadia. "Vaccination du chien contre la rage : fabrication et contrôles d'un vaccin à virus inactivé préparé sur encéphale d'agneau : étude comparée de l'activité de deux vaccins sur des chiens du terrain en Tunisie." Lyon 1, 1985. http://www.theses.fr/1985LYO10122.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Sagodira, Serge. "Vaccination génétique par voie nasale contre la cryptosporidiose : étude de la réponse immunitaire chez la souris et de la protection dans un modèle caprin." Tours, 1998. http://www.theses.fr/1998TOUR3808.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Vaccination – Immunologie"

1

Symposium in Immunology (7th 1997?). Symposium in Immunology VII: Vaccination. Springer, 1998.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

1956-, Zhang Jingwu, and Cohen Irun R, eds. T-cell vaccination. Nova Biomedical Books, 2008.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

E, Kaufmann S. H., ed. Novel vaccination strategies. Wiley-VCH, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Ada, G. L. Vaccination: The facts, the fears, the future. Allen & Unwin, 2000.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

J, Raus, ed. T cell vaccination and autoimmune disease. Springer-Verlag, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Foged, Camilla. Subunit vaccine delivery. Edited by Rades Thomas author, Perrie Yvonne author, and Hook Sarah author. Springer, 2015.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Alejandro, Schudel, Lombard Michel, and International Office of Epizootics, eds. Control of infectious animal diseases by vaccination: Buenos Aires, Argentina, 13-16 April, 2005 ; proceedings of a conference organized by the World Organisation for Animal Health-OIE. Karger, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Alejandro, Schudel, and Lombard Michel, eds. Control of infectious animal diseases by vaccination: Buenos Aires, Argentina, 13-16 April, 2005. Karger, 2005.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

International, Meeting on the History of Vaccinology (1995 Marnes-la Coquette Hauts-de-Seine). Vaccinia, vaccination, vaccinology: Jenner, Pasteur, and their successors. Elsevier, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Aronova, E. A. Immunitet: Teorii︠a︡, filosofii︠a︡ i ėksperiment : ocherki iz istorii immunologii XX veka. KomKn., 2006.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Vaccination – Immunologie"

1

Catchpole, Brian, and Harm HogenEsch. "Vaccination." In Day's Veterinary Immunology, 3rd ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781003310969-13.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Klimov, Vladimir V. "Vaccination." In From Basic to Clinical Immunology. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03323-1_8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Jaspreet, Dhami, Wang Vivian, Wang Ziwei, Pham Brittney, Yabuno Jamie, and Joseph Yusin. "Vaccination." In Absolute Allergy and Immunology Board Review. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-12867-7_30.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Durrant, L. G., I. Spendlove, and R. A. Robins. "Anti-idiotypic vaccination." In Cancer Immunology. Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-017-0963-7_10.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Rijkers, G. T. "17 Vaccins en vaccinatie." In Immunologie. Bohn Stafleu van Loghum, 2009. http://dx.doi.org/10.1007/978-90-313-6528-9_17.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Rijkers, G. T., and F. G. M. Kroese. "Vaccins en vaccinatie." In Leerboek immunologie. Bohn Stafleu van Loghum, 2023. http://dx.doi.org/10.1007/978-90-368-2817-8_16.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Rijkers, G. T. "Vaccins en vaccinatie." In Leerboek immunologie. Bohn Stafleu van Loghum, 2016. http://dx.doi.org/10.1007/978-90-368-0258-1_17.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Cohen, Noah D., and Angela I. Bordin. "Principles of Vaccination." In Equine Clinical Immunology. John Wiley & Sons, Inc., 2015. http://dx.doi.org/10.1002/9781119086512.ch28.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Sharapova, Svetlana O. "Fever After DPT Vaccination." In Pediatric Immunology. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-21262-9_49.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Huizinga, T. W. J., and L. G. Visser. "15 Vaccinatie en immunomodulatie." In Medische immunologie. Bohn Stafleu van Loghum, 2016. http://dx.doi.org/10.1007/978-90-368-1613-7_15.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Vaccination – Immunologie"

1

Telgen, Maaike C., M. G. J. Brusse-Keizer, G. T. Rijkers, et al. "Immunologic Responses In COPD Patients: The Annual Influenza Vaccination." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2270.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Pamar, P., K. Krolikowski, D. Rudym, et al. "Immunologic Effects of SARS-CoV-2 Vaccination in Lung Transplant Recipients." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6044.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Garrido, Greta, Brett Schrand, Agata Levay, et al. "Abstract B26: Prorapeutic vaccination against shared antigens induced in future tumors." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 17-20, 2019; Boston, MA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm19-b26.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Brody, Joshua D. "Abstract IA32: Improving checkpoint blockade for lymphoma with Flt3L-primed in situ vaccination." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; October 1-4, 2017; Boston, MA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/2326-6074.tumimm17-ia32.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Kim, Ha, Keejong Hong, Byung Cheol Ahn, Jung Sun Yum, and Hyewon Youn. "Abstract B25: Visualization of immune response to Hepatitis B vaccination by in vivo mouse imaging." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; October 20-23, 2016; Boston, MA. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/2326-6074.tumimm16-b25.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Carpanese, D., I. Montagner, A. Dalla Pietà, et al. "P09.03 Hyaluronic acid as a new immunologic adjuvant in cancer: design of effective preventive and therapeutic vaccination strategies for HER2/neu-positive breast tumors." In iTOC8 – the 8th Leading International Cancer Immunotherapy Conference in Europe, 8–9 October 2021, Virtual Conference. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/jitc-2021-itoc8.53.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Marron, Thomas, Nina Bhardwaj, Elizabeth Crowley, et al. "Abstract IA03: Turning a tumor into a vaccine factory: In situ vaccination for low-grade lymphoma." In Abstracts: AACR Special Conference: Tumor Immunology and Immunotherapy: A New Chapter; December 1-4, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/2326-6074.tumimm14-ia03.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Witt, Kristina, Maarten Alexander Ligtenberg, Laura Conti, et al. "Abstract A77: Cripto-1 vaccination elicits protective immune response to metastatic breast cancer and breast cancer stem cells." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; October 1-4, 2017; Boston, MA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/2326-6074.tumimm17-a77.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Schreiber, Taylor H., Louis Gonzalez, Dietlinde Wolf, Maria Bodero, and Eckhard R. Podack. "Abstract A38: T cell costimulation by TNFRSF4, TNFRSF18, and TNFRSF25 in the context of vaccination." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-a38.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Andersen, Brian M., G. Elizabeth Pluhar, Charles E. Seiler, et al. "Abstract B32: Preclinical testing of three immune adjuvants in vaccination therapy for invasive canine meningioma." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-b32.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!